The authors used a novel analytical lens to justify the placement of a clinical pharmacist on an inpatient unit within an academic health center. From a financial cost–benefit perspective, we found that the assignment of a clinical pharmacist had a positive return of approximately $65,000. By coupling the financial analysis with another interesting evaluation method—hermeneutics— we were able to interpret the nontangible constraints that may be preventing support for the clinical pharmacy service. By mitigating the nontangible constraints, we hope to increase the hospital administrator's willingness to accept the program.
StarfieldB.Quality-of-care research: Internal elegance and external relevance. JAMA.1998; 280(11): 1006–8.
2.
LeapeL.L.Pharmacist participation on physician tounds and adverse drug events in the intensive care unit. JAMA.1999; 282(3): 267–70.
3.
McMullinS TroyA prospective randomized trial to assess the cost impact of pharmacist-initiated interventions. Arch Intern Med.1999; 159: 2306–9.
4.
JamesonJ.The impact of a pharmacotherapy consultation on the cost and outcome of medical therapy. J Fam Pract.1995; 41: 469–72.
5.
CarterBL.The IMPROVE study: Background and study design. Am J Health-Syst Pharm.1998; 55: 62–7.
6.
CassidyI.B.Impact of pharmacist-operated general medicine chronic care relief clinics on practitioner time and quality of care. Ann Pharmacother.1996; 30: 745–50.
7.
BjornsonD.C.Effect of pharmacists on health care outcomes in hospitalized patients. Am J Hosp Pharm.1993; 50: 1875–84.
8.
SchumockG.T.Economic evaluations of clinical pharmacy services— 1988–1995. Pharmacotherapy.1996; 16(6): 1188–208.
9.
See ref. 1.
10.
HeideggerM.What is Called Thinking? Trans. J. G. Gray. New York: Harper and Row; 1968.
